Disparities Details by Geographic Location for 2015-17
STD-5 : Females ever treated for pelvic inflammatory disease (percent, 15–44 years)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Geographic Location for STD-5
STD-5 Reduce the proportion of females aged 15 to 44 years who have ever required treatment for pelvic inflammatory disease (PID)
Females ever treated for pelvic inflammatory disease (percent, 15–44 years)
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 3.2%, was attained by persons living in a metropolitan area.
- The worse group rate for this objective, 3.3%, was attained by persons living in a non-metropolitan area.
- The absolute difference (or range) between the best and worst group rates was 0.1 percentage points.
- The worst group rate was <1.100 times the best group rate.
Persons living in a metropolitan area achieved the better group rate for this objective, 3.2%.
The rate among persons living in a non-metropolitan area was <1.1 times the better group rate.